Download Slides

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Increased Postoperative Complications in
Bilateral Mastectomy Patients Compared
to Unilateral Mastectomy: An Analysis of
NSQIP Database
Osman F, Saleh F, Corrigan M, Jackson T, Cil T.
University of Toronto, Toronto, Canada
Introduction
• The rate of contralateral prophylactic
mastectomy among women with unilateral
breast cancer has increased
• Incidence of contralateral breast cancer is
very low
• Post-operative complications: Bilateral >
Unilateral?
Method
ACS- NSQIP Data 2007-2010
All Mastectomy Patients
N= 20,322
HighOther
Risk procedures
Pre-operative
Characteristics
Two
Sentinelcoding
Node
(Reconstruction,
Ambiguous
Axillary
dissection
etc.)
Biopsy
Code
Steroids,
Infections
and
Missing
Data
Dialysis,
Etc.
N=12,
714
N=
769
N=
1,426
N= 1194
Unilateral and Bilateral
Mastectomies with
SLNB
4,219
Unilateral Mastectomy
with SLNB
Bilateral Mastectomy
with SLNB
3, 722
497
Results: Baseline Characteristics
Unilateral
Mastectomy and
sentinel lymph node
biopsy
N (%)
Bilateral Mastectomy and
sentinel lymph node
biopsy
P-Value
N = 4,219
3,722(88.2)
497 (11.8)
N/A
Mean Age ( SD)
64.2 (13.0)
58.6 (11.8)
P<0.001
Hypertension
1,979 (50.1)
182 (39.1)
P<0.001
N (%)
ASA b
P=0.020
ASA 1
177 (4.5)
26 (5.6)
ASA 2
2,362 (59.8)
306 (65.8)
ASA 3
1,363 (34.5)
130 (28.0)
ASA 4
46 (1.2)
3 (0.7)
Diabetic
509 (12.9)
37 (8.0)
P<0.002
Mean BMI ( SD) c
28.4 (6.9)
29.2 (7.1)
P=0.024
Coronary Artery disease
185 (4.7)
15 (3.2)
P=0.193
COPD d
145 (3.7)
9 (1.9)
P=0.060
ETOH e
49 (1.2)
5 (1.1)
P=1.000
Smoker a
565 (14.3)
65 (14.0)
P<0.846
Chemotherapyf
48 (1.2)
13 (2.8)
P=0.011
Results
Complication
Unilateral
Mastectomy and
SLNB
N (%)
Bilateral Mastectomy OR (95% CI)
and SLNB
N (%)
Overall
Complications**
164 (4.2)
39 (7.6)
1.9 (1.3 –2.8)
Wound **
106 (2.9)
29 (5.8)
2.1 (1.3- 3.3)
Infectious **
29 (0.8)
11 (2.2)
2.9 (1.3- 6.0)
Respiratory
5 (0.1)
0 (0.0)
(0.0, 5.8)
Thromboembolic
10 (0.3)
1 (0.2)
0.7 (0.0, 5.3)
Renal
1 (0.03)
0 (0.0)
N/A
Neurologic
3 (0.1)
1 (0.2)
2.5 (0.04, 31.2)
Cardiac
2 (0.1)
0 (0.0)
0.0 (0.0, 14.4)
Bleeding
15 (0.4)
0 (0.0)
0.0 (0.0, 1.9)
**P-value <0.05
Multivariable Analysis of
Overall Complications
OR (95% CI)
P-Value
Bilateral vs. Unilateral
mastectomy with sentinel
lymph node biopsy
Age
1.9 (1.3- 2.8)
0.001
1.01 (1.00 - 1.02)
0.132
Diabetes
1.3 (0.9 - 1.9)
0.213
Smoker
2.2 (1.5 - 3.2)
<0.001
Body Mass Index
1.1 (1.0 - 1.1)
<0.001
Chronic obstructive pulmonary
disease
1.3 (0.7 - 2.4)
0.495
Coronary artery disease
1.4 (0.8 - 2.5)
0.246
Hypertension
1.0 (0.7 - 1.4)
0.900
ASA 3 and 4*
1.0 (0.8 - 1.5)
0.721
Chemotherapy
0.9 (0.2- 3.8)
0.877
Limitations of the Study
• Only Short-term outcomes (30-day)
• Cancer stage not reported in NSQIP data
• Procedural codes: CPM
• No Reconstruction
Conclusion
• Bilateral mastectomy appears to be associated
with an increased risk of overall post-operative
wound and other infections.
• Further studies are warranted to examine short term
and long-term complications of CPM and whether
these complications delay treatment.
Related documents